CD8A and cerebral malaria: In vivo administration of 6-diazo-5-oxo-L-norleucine (DON) late in the course of infection, when the mice have already triggered endothelial dysfunction due to the action of CD8+ T cell responses, was able to rescue the clinical manifestation signs of cerebral malaria.